Showing results (231-240 of 267) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, BelgiumJ Klastersky, J P Sculier, G Bureau, et al.Lung Cancer (Amsterdam, Netherlands)|July 6, 2000
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.comJ P Sculier, J J Lafitte, T Berghmans, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working PartyJ P Sculier, J Klastersky, V Giner, et al.Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium)J P Sculier, J Klastersky, J P Dumont, et al.The Journal of Antimicrobial Chemotherapy|October 1, 1991
Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patientsO Ringdén, F Meunier, J Tollemar, et al.European Journal of Cancer & Clinical Oncology|March 1, 1988
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancerJ P Sculier, J Klastersky, D Becquart, et al.Antimicrobial Agents and Chemotherapy|February 1, 1995
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerA Cometta, S Zinner, R de Bock, et al.European Journal of Cancer & Clinical Oncology|June 1, 1989
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumorsR A Stahel, J P Sculier, L M Jost, et al.European Journal of Cancer & Clinical Oncology|January 1, 1988
Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trialsJ Klastersky, S H Zinner, T Calandra, et al.British Journal of Cancer|February 20, 2003
Impact of medical specialists' locus of control on communication skills in oncological interviewsY Libert, P Janne, D Razavi, et al.Pageof 27